Drugs / Fotemustin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02843386 | Jun 2009 → Jun 2020 | uveal melanoma | Institut Curie | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fotemustin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02843386 ↗ |
| Route | Intravenous | “1 hour IV infusion” NCT02843386 ↗ |